Monthly Archives: October 2011
When Do You Stop Doing The Things You Enjoy?
Hello to all friends and supporters of my website. It is a while since I wrote about my personal journey with myelofibrosis, it is not always easy to put thoughts together that not only help me to cope with this disease, but also, hopefully, help others as well. It is… Continue reading
S*BIO to Initiate Global Phase 3 Clinical Trials of its Novel JAK2 Inhibitor Pacritinib for Treatment of Myelofibrosis (MF)
-S*BIO Explores Partnering Opportunities for Advancement of its Leading JAK2 Program-
PR Newswire
SINGAPORE, Oct. 25, 2011
SINGAPORE, Oct. 25, 2011 /PRNewswire/ — S*BIO Pte Ltd today announced plans to initiate a global Phase 3 clinical program of its novel JAK2 inhibitor pacritinib (SB1518), in the first half of 2012… Continue reading
Will Incyte’s COMFORTs Excite FDA?
10/11/2011 5:26 AM ET
(RTTNews) – Incyte Corp. (INCY: News ) may soon learn the fate of its myelofibrosis drug Ruxolitinib, which if approved , will be the first effective drug for the potentially life-threatening disorder characterized by scarring of tissue in the bone marrow.
Myelofibrosis, which affects about 3,500… Continue reading